Search research articles
Contact Us
Filters
Showing results (1-10 of 86) with videos related to
Page
of 9
Sort By:
International Journal of Obesity (2005)
|
November 29, 2007
Role of obesity and adiposity in polycystic ovary syndrome
E Diamanti-Kandarakis
Current Pharmaceutical Design
|
September 25, 1999
Current aspects of antiandrogen therapy in women
E Diamanti-Kandarakis
Annals of the New York Academy of Sciences
|
June 17, 1997
The polycystic ovary syndrome. Pathogenesis, metabolic implications, and therapeutic approach
E Diamanti-Kandarakis
Journal of Endocrinological Investigation
|
December 18, 1998
How actual is the treatment with antiandrogen alone in patients with polycystic ovary syndrome?
E Diamanti-Kandarakis
Annals of the New York Academy of Sciences
|
December 29, 1995
Distress amenorrhea
G Tolis, E Diamanti
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
July 18, 2002
The influence of obesity on hyperandrogenism and infertility in the female
E Diamanti-Kandarakis, A Bergiele
Diabetologia
|
February 8, 2012
Oral glucose tolerance test in patients with undiagnosed diabetes and coronary artery disease: when should it be performed?
A Kollias, E Diamanti-Kandarakis
Journal of Endocrinological Investigation
|
February 28, 2009
The effects of insulin sensitizers on the cardiovascular risk factors in women with polycystic ovary syndrome
E Kassi, E Diamanti-Kandarakis
Trends in Endocrinology and Metabolism: TEM
|
October 1, 1996
New perspectives in polycystic ovary syndrome
E Diamanti-Kandarakis, A Dunaif
Annales D'Endocrinologie
|
August 11, 2007
Metabolic syndrome: a contemporary fuel excess syndrome and its specific impact in women
E Diamanti-Kandarakis, G Argyrakopoulou
Page
of 9
Search research articles
Search
Showing results (1-10 of 86) with videos related to
Sort By:
Page
of 9
International Journal of Obesity (2005)
|
November 29, 2007
Role of obesity and adiposity in polycystic ovary syndrome
E Diamanti-Kandarakis
Current Pharmaceutical Design
|
September 25, 1999
Current aspects of antiandrogen therapy in women
E Diamanti-Kandarakis
Annals of the New York Academy of Sciences
|
June 17, 1997
The polycystic ovary syndrome. Pathogenesis, metabolic implications, and therapeutic approach
E Diamanti-Kandarakis
Journal of Endocrinological Investigation
|
December 18, 1998
How actual is the treatment with antiandrogen alone in patients with polycystic ovary syndrome?
E Diamanti-Kandarakis
Annals of the New York Academy of Sciences
|
December 29, 1995
Distress amenorrhea
G Tolis, E Diamanti
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
July 18, 2002
The influence of obesity on hyperandrogenism and infertility in the female
E Diamanti-Kandarakis, A Bergiele
Diabetologia
|
February 8, 2012
Oral glucose tolerance test in patients with undiagnosed diabetes and coronary artery disease: when should it be performed?
A Kollias, E Diamanti-Kandarakis
Journal of Endocrinological Investigation
|
February 28, 2009
The effects of insulin sensitizers on the cardiovascular risk factors in women with polycystic ovary syndrome
E Kassi, E Diamanti-Kandarakis
Trends in Endocrinology and Metabolism: TEM
|
October 1, 1996
New perspectives in polycystic ovary syndrome
E Diamanti-Kandarakis, A Dunaif
Annales D'Endocrinologie
|
August 11, 2007
Metabolic syndrome: a contemporary fuel excess syndrome and its specific impact in women
E Diamanti-Kandarakis, G Argyrakopoulou
Page
of 9